Riser pattern is a predictor of kidney mortality among patients with chronic kidney disease

Kentaro Nakai1, Hideki Fujii1, Kentaro Watanabe1

  • 1a Division of Nephrology and Kidney Center , Kobe University Graduate School of Medicine , Kobe , Japan.

Insights

In chronic kidney disease (CKD) patients, a rising blood pressure (BP) pattern overnight, known as the riser pattern, is linked to worse kidney survival. This risk is amplified in patients with elevated brain natriuretic peptide (BNP) levels.

Area of Science:

  • Nephrology
  • Cardiology
  • Hypertension Research

Background:

  • Hypertension is a major risk factor for cardiovascular mortality and loss of kidney function.
  • The absence of a normal nocturnal blood pressure (BP) decline indicates poor prognosis.
  • Characteristics of hypertension in moderate-to-severe chronic kidney disease (CKD) require further evaluation.

Purpose of the Study:

  • To assess the circadian variation of BP in CKD patients.
  • To evaluate the impact of BP circadian rhythm on kidney survival.
  • To determine the role of brain natriuretic peptide (BNP) in kidney prognosis.

Main Methods:

  • 124 patients with moderate-to-severe CKD (eGFR <45 ml/min/1.73 m²) were enrolled.
  • 24-hour ambulatory BP monitoring (ABPM) was used to assess BP circadian patterns.
  • The association between BP patterns, BNP levels, and kidney survival was analyzed.

Main Results:

  • 45% of patients exhibited a non-dipper BP pattern, 35% a riser pattern, and 19% a dipper pattern.
  • The riser-pattern group had higher prevalence of diabetes, elevated BNP, and lower eGFR compared to non-risers.
  • Kidney survival was significantly worse in the riser-pattern group, especially those with higher BNP levels.

Conclusions:

  • The riser BP pattern is common in CKD and associated with increased risk for kidney survival.
  • CKD patients with a riser BP pattern and elevated BNP levels face a poorer kidney prognosis.
  • Circadian BP variations, particularly the riser pattern, are critical markers for kidney health in CKD.
Abstract

Related Concept Videos

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
292
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
586
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1000
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
455
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
1.1K
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.2K